Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment?-Reference-Cited by-同舟云学术

Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment?

Author:

Albayrak Ayse¹,Uyanik Muhammet H.²,Cerrah Serkan³,Altas Sare⁴,Dursun Hakan³,Demir Mehmet⁵,Uslu Hakan²

Affiliation:

1. Department of Infectious Diseases and Clinical Microbiology, Erzurum Region Education and Research Hospital, Erzurum, Turkey.

2. Department of Microbiology, Ataturk University School of Medicine, Erzurum, Turkey.

3. Department of Internal Medicine, Ataturk University School of Medicine, Erzurum, Turkey.

4. Department of Pathology, Ataturk University School of Medicine, Erzurum, Turkey.

5. Department of Internal Medicine, Division of Gastroenterology, Mustafa Kemal University School of Medicine, Hatay, Turkey.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

Reference31 articles.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献